(0.17%) 5 530.75 points
(0.15%) 39 527 points
(0.18%) 19 963 points
(0.75%) $82.15
(-1.00%) $2.58
(-0.23%) $2 334.20
(-0.24%) $29.49
(0.36%) $1 005.50
(-0.50%) $0.929
(-0.59%) $10.61
(-0.25%) $0.789
(1.64%) $87.13
Live Chart Being Loaded With Signals
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom...
Stats | |
---|---|
今日成交量 | 263 894 |
平均成交量 | 110 470 |
市值 | 122.39M |
EPS | $-0.0416 ( Q2 | 2023-12-31 ) |
下一个收益日期 | ( $0 ) 2024-07-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-10.00 (Sector) 0 (Industry) 0 |
ATR14 | $0.00900 (1.50%) |
Recce Pharmaceuticals Ltd 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Recce Pharmaceuticals Ltd 财务报表
Annual | 2023 |
营收: | $4.37M |
毛利润: | $4.15M (95.03 %) |
EPS: | $-0.0744 |
FY | 2023 |
营收: | $4.37M |
毛利润: | $4.15M (95.03 %) |
EPS: | $-0.0744 |
FY | 2022 |
营收: | $3.08M |
毛利润: | $2.90M (93.92 %) |
EPS: | $-0.0625 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.143 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Recce Pharmaceuticals Ltd
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。